INSTRUCTIONS Female adolescents and sexual health: “I think I'm okay, but am I?”
- To take the test online, go to our secure website at www.nursingcenter.com/ce/nursing View instructions for taking the test online there.
- If you prefer to submit your test by mail, record your answers in the test answer section of the CE enrollment form on page 42. You may make copies of the form. Each question has only one correct answer. There is no minimum passing score required.
- Complete the registration information and course evaluation. Mail the completed form and registration fee of $12.95 to: Lippincott Professional Development, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
- You will receive your CE certificate of earned contact hours and an answer key to review your results.
- Registration deadline is March 6, 2020.
DISCOUNTS and CUSTOMER SERVICE
- Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together by mail, and deduct $0.95 from the price of each test.
- We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Professional Development will award 1.0 contact hour for this continuing nursing education activity.
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida CE Broker #50-1223. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.0 contact hour.
Female adolescents and sexual health: “I think I'm okay, but am I?”
GENERAL PURPOSE: To provide nurses with information about adolescent sexual health. LEARNING OBJECTIVES/OUTCOMES: After completing this continuing-education activity, you should be able to: 1. List the most common STIs in adolescents. 2. Compare contraceptive effectiveness for reducing unintended pregnancies. 3. Identify issues surrounding HPV vaccination.
- Which is included in the five Ps of a sexual health history?
- Which are the two most common reportable diseases in the United States?
- syphilis and hepatitis B
- chlamydia and gonorrhea
- HPV and HIV
- Of reported chlamydia infections, 65% occur in people ages
- 15 to 24.
- 25 to 40.
- 41 to 65.
- Untreated chlamydia and gonorrhea infections in female adolescents can cause long-term complications including
- anogenital warts.
- Females can collect samples for NAAT for chlamydia and gonorrhea screening with a self-administered
- rectal swab.
- vaginal swab.
- oropharyngeal swab.
- Current cervical screening guidelines recommend Pap testing to begin at age
- ACOG recommends that sexually active female adolescents should be screened for gonorrhea and chlamydia every
- 3 years.
- 2 years.
- Compared with LARC use, short-term contraceptive use is associated with unintended pregnancy rates that are
- slightly lower.
- much higher.
- Adolescents' most frequently selected method of contraception is
- contraceptive implants.
- intrauterine devices.
- oral contraceptives.
- A Yuzpe regimen consists of
- a single dose of levonorgestrel.
- two doses of levonorgestrel.
- ethinyl estradiol plus levonorgestrel.
- The oncogenic HPV strains are
- 6 and 11.
- 16 and 18.
- 31 and 33.
- Before age 15, the recommended HPV vaccination schedule consists of a
- single dose.
- two-dose series.
- three-dose series.
- Patients with a latex hypersensitivity should not receive
- Gardasil 9.
- Many female patients diagnosed with chlamydia
- are asymptomatic.
- complain of dysuria.
- experience intermittent bleeding.
- EPT involves providing
- a prescription for partners of infected patients without an office visit.
- an expedited office visit (within 2 days) for partner treatment.
- treatment for an infected patient's partner in an urgent care or ED setting.
- With disclosure of STIs, the first priority is to
- find out if any partners have a healthcare provider.
- request the health department to anonymously advise partners.
- determine if the patient can safely disclose STI status to intimate partners.
- If an adolescent's previous confidant discloses her STI status on social media, it's considered
- digital abuse.
- social engineering.
- Patients who have completed treatment for chlamydia should return for repeat testing in
- 3 weeks.
- 3 months.
- 1 year.